INTRODUCTION: Opioid overdoses are a major public health emergency in the United States. Despite effective treatments that can save lives, access to and utilization of such treatments are limited. Community context plays an important role in addressing treatment barriers and increasing access. The HEALing Communities Study (HCS) is a multisite community-level cluster-randomized trial that will study implementation and outcomes of a community coalition-based intervention (Communities that HEAL [CTH]) that implements evidence-based practices (EBPs) to reduce opioid overdose deaths in four states. To examine contextual factors critical to understanding implementation, we assessed the perspectives of community members about their communities, current substance use-related services, and other important issues that could impact intervention implementation. METHODS: Researchers conducted 382 semi-structured qualitative interviews in the HCS communities. Interviews were audio-recorded and transcribed; researchers subsequently analyzed data using directed content analysis based on the constructs of the RE-AIM/PRISM implementation science framework to identify key themes within the external community context. RESULTS: Despite the diversity in states and communities, four similar themes related to the external community context emerged across communities: These themes included the importance of understanding: 1) community risk perceptions, 2) levels of stigma, 3) the health services environment and the availability of substance use services, and 4) funding for substance use services. CONCLUSION: Understanding and addressing the external community context in which the CTH intervention and EBPs are implemented are crucial for successful health services-related and community engaged interventions. While implementing EBPs is a challenging undertaking, doing so will help us to understand if and how a community-based intervention can successfully reduce opioid overdose deaths and influence both community beliefs and the community treatment landscape.
INTRODUCTION: Opioid overdoses are a major public health emergency in the United States. Despite effective treatments that can save lives, access to and utilization of such treatments are limited. Community context plays an important role in addressing treatment barriers and increasing access. The HEALing Communities Study (HCS) is a multisite community-level cluster-randomized trial that will study implementation and outcomes of a community coalition-based intervention (Communities that HEAL [CTH]) that implements evidence-based practices (EBPs) to reduce opioid overdose deaths in four states. To examine contextual factors critical to understanding implementation, we assessed the perspectives of community members about their communities, current substance use-related services, and other important issues that could impact intervention implementation. METHODS: Researchers conducted 382 semi-structured qualitative interviews in the HCS communities. Interviews were audio-recorded and transcribed; researchers subsequently analyzed data using directed content analysis based on the constructs of the RE-AIM/PRISM implementation science framework to identify key themes within the external community context. RESULTS: Despite the diversity in states and communities, four similar themes related to the external community context emerged across communities: These themes included the importance of understanding: 1) community risk perceptions, 2) levels of stigma, 3) the health services environment and the availability of substance use services, and 4) funding for substance use services. CONCLUSION: Understanding and addressing the external community context in which the CTH intervention and EBPs are implemented are crucial for successful health services-related and community engaged interventions. While implementing EBPs is a challenging undertaking, doing so will help us to understand if and how a community-based intervention can successfully reduce opioid overdose deaths and influence both community beliefs and the community treatment landscape.
Authors: Tamara Beetham; Brendan Saloner; Sarah E Wakeman; Marema Gaye; Michael L Barnett Journal: Ann Intern Med Date: 2019-06-04 Impact factor: 25.391
Authors: Sarah E Wakeman; Marc R Larochelle; Omid Ameli; Christine E Chaisson; Jeffrey Thomas McPheeters; William H Crown; Francisca Azocar; Darshak M Sanghavi Journal: JAMA Netw Open Date: 2020-02-05
Authors: Kristin E Schneider; Allison O'Rourke; Rebecca Hamilton White; Ju Nyeong Park; Raschelle J Musci; Michael E Kilkenny; Susan G Sherman; Sean T Allen Journal: Int J Drug Policy Date: 2020-01-07
Authors: Leonieke C van Boekel; Evelien P M Brouwers; Jaap van Weeghel; Henk F L Garretsen Journal: Drug Alcohol Depend Date: 2013-03-13 Impact factor: 4.492
Authors: Melissa Davoust; Valerie Grim; Allie Hunter; David K Jones; David Rosenbloom; Michael D Stein; Mari-Lynn Drainoni Journal: Int J Drug Policy Date: 2021-02-02
Authors: Kerry Nolte; Aurora L Drew; Peter D Friedmann; Eric Romo; Linda M Kinney; Thomas J Stopka Journal: Drug Alcohol Depend Date: 2020-08-30 Impact factor: 4.492
Authors: Bethany M Kwan; Hannah L McGinnes; Marcia G Ory; Paul A Estabrooks; Jeanette A Waxmonsky; Russell E Glasgow Journal: Front Public Health Date: 2019-11-22
Authors: Daniel M Walker; Janet E Childerhose; Sadie Chen; Nicolette Coovert; Rebecca D Jackson; Natasha Kurien; Ann Scheck McAlearney; Jaclyn Volney; Daniel P Alford; Julie Bosak; Douglas R Oyler; Laura K Stinson; Melika Behrooz; Mia-Cara Christopher; Mari-Lynn Drainoni Journal: Drug Alcohol Depend Date: 2022-02-02 Impact factor: 4.492